XT
AXDX

XTX Topco’s Accelerate Diagnostics AXDX Stock Holding History

XTX Topco’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,687
Closed -$10.6K – 1862
2024
Q1 		$10.6K Buy
+10,687
New +$16.9K ﹤0.01% 1672
2022
Q4 		– Sell
-3,118
Closed -$47K – 1118
2022
Q3 		$47K Buy
+3,118
New +$51.6K 0.01% 1030

Other funds holding AXDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CS
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco's AXDX Position: Q2 2024 in Review

XTX Topco sold out of Accelerate Diagnostics (AXDX) in Q2 2024, closing a stake of 10,687 shares — an estimated $10.6K sold.

XTX Topco first reported a position in AXDX in Q3 2022 and held it in 2 quarters. The position peaked at $47K in Q3 2022. 41 funds tracked by Wall St. Rank hold AXDX as of Q2 2024.

  • XTX Topco reported no remaining Accelerate Diagnostics position as of Q2 2024 after selling out during the quarter.
  • XTX Topco sold 10,687 Accelerate Diagnostics shares in Q2 2024, an estimated $10.6K.
  • XTX Topco first reported a position in Accelerate Diagnostics in Q3 2022 and held it in 2 quarters.
  • XTX Topco's Accelerate Diagnostics position peaked at $47K in Q3 2022.
  • 41 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2024.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.